In this study, administration of the MCHR1 antagonist SNAP reversed the inhibitory effect exerted by MCH on HFD mice during the sucrose preference test, which aligns with the therapeutic effects observed with MCHR1 antagonists for treating depression (55). This evidence concerns the gene MCHR1 and depressive symptom measurement.